NCT02488135View on ClinicalTrials.gov

Management of Persistent Epistaxis Using Floseal Hemostatic Matrix

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

March 1, 2017

Study Completion Date

March 1, 2017

Conditions
Epistaxis
Interventions
DEVICE

Floseal Hemostatic Matrix

Floseal Hemostatic Matrix is a gel like fibrin glue used topically in the nasal cavity and applied with a syringe.

PROCEDURE

Traditional Nasal Packing

Using either vaseline gauze or nasal merocels. These will be placed in the anterior nasal cavity using nasal speculum and forceps.

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02488135 - Management of Persistent Epistaxis Using Floseal Hemostatic Matrix | Biotech Hunter | Biotech Hunter